Oakville Cardiovascular Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Stroke2 trials
• Heart failure1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Amgen2 trials
• Bayer1 trial

Running trials

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting

Closed trials

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Bayer· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source